| Literature DB >> 25187102 |
Yara Dadalti Fragoso1, Tarso Adoni2, Soniza Vieira Alves-Leon3, Nerio Dutra Azambuja4, Amilton Antunes Barreira5, Joseph Bruno Bidin Brooks6, Denise Sisteroli Diniz Carneiro7, Margarete J Carvalho8, Rinaldo Claudino9, Elizabeth Regina Comini-Frota10, Renan Barros Domingues11, Alessandro Finkelsztejn12, Paulo Diniz Gama13, Maria Cristina Brandao Giacomo14, Sidney Gomes15, Marcus Vinicius Magno Goncalves16, Anderson Kuntz Grzesiuk17, Damacio Ramon Kaimen-Maciel18, Maria Fernanda Mendes19, Nivea Macedo Oliveira Morales20, Rogerio Rizo Morales20, Andre Muniz21, Regina Maria Papais-Alvarenga22, Monica Koncke Fiuza Parolin23, Sonia Beatriz Felix Ribeiro24, Heloisa Helena Ruocco25, Pedro Rippel Salgado26, Fabio Siquineli27, Doralina Brum Souza5, Elza Dias Tosta28, Claudia Cristina Ferreira Vasconcelos22, Sandra Maria Garcia Almeida3, Daniella Freire Ribeiro Bernardes21, Simone Nascimento Castro26, Rodrigo Assad Diniz Gama13, Fabrizio Antonio Resende Gomide24, Juliana Finkelzstejn12, Josiane Lopes18, Fabiani Honorato de Barros Lourenco26, Gisele A Lourenco3, Celso Luis Silva Oliveira6, Francisco Tomaz Meneses Oliveira15, Lucas Felix Oliveira24, Cristiane Borges Patroclo3, Wildea Lice de Carvalho Jennings Pereira18, Juliana Safanelli16, Alinne Martiniano Sahdo28, Patricia Correa de Oliveira Saldanha11, Yves Fumio Shinzato13, Jorge Murilo Barbosa Souza9, Denis Evandro Zani13.
Abstract
Multiple sclerosis (MS) is a chronic, neurological, immune-mediated disease that can worsen in the postpartum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. We have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.Entities:
Mesh：
Substances：
Year: 2014 PMID： 25187102 DOI： 10.1080/07399332.2014.948627
Source DB: PubMed Journal: Health Care Women Int ISSN： 0739-9332